Edition:
United States

Pacira Pharmaceuticals Inc (PCRX.OQ)

PCRX.OQ on NASDAQ Stock Exchange Global Select Market

34.02USD
29 Sep 2016
Change (% chg)

-- (--)
Prev Close
$34.02
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
252,636
52-wk High
$80.24
52-wk Low
$31.08

PCRX.OQ

Chart for PCRX.OQ

About

Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is focused on the development, commercialization and manufacture of pharmaceutical products, based on its DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. Its primary focus lies in the development of non-opioid... (more)

Overall

Beta: 1.97
Market Cap(Mil.): $1,268.20
Shares Outstanding(Mil.): 37.28
Dividend: --
Yield (%): --

Financials

  PCRX.OQ Industry Sector
P/E (TTM): -- 37.66 37.54
EPS (TTM): -0.31 -- --
ROI: -4.88 14.54 13.98
ROE: -5.30 15.32 14.88

BRIEF-Pacira Pharmaceuticals announces official launch of Exparel

* Pacira Pharmaceuticals announces official launch of Exparel to the Oral Surgeon community to treat pain following Oral and Maxillofacial procedures Source text for Eikon: Further company coverage:

Sep 21 2016

BRIEF-Pacira Pharmaceuticals Q2 GAAP loss per share $0.21

* Q2 earnings per share view $0.03 -- Thomson Reuters I/B/E/S

Aug 04 2016

BRIEF-Pacira Pharmaceuticals to pay termination fee of about $7.3 mln to CrossLink

* In connection with termination of agreement, fee based on percentage of earned performance-based fees will be due to CrossLink

Jul 01 2016

BRIEF-Pacira Pharmaceuticals Q1 non-gaap earnings per share $0.14

* Pacira pharmaceuticals, inc. Reports first quarter 2016 financial results

May 02 2016

BRIEF-Pacira Pharmaceuticals appoints Charles Reinhart, III, as CFO

* Charles Reinhart, III will succeed former chief financial officer Jim Scibetta Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Apr 19 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.